To explore the potential hematologic toxicity in elderly epilepsy patients treated with sodium valproate(VPA)and the impact of polypharmacy on medication safety by analysis of the situation of thrombocytopenia(PLT reduction)and hypofibrinogenemia(FIB reduction)in an elderly patient following the treatment of epilepsy with VPA.During the treatment,the pharmacists recommended a adjustment of the dose of VPA according to the specific condition of the patient,and closely monitored the patient's blood routine and coagulation function indicators.This case emphasizes the importance of pharmacists'ability to identify and manage adverse drug reactions in clinical treatment,and at the same time highlights the use of their professional knowledge to analyze and monitor adverse drug reactions to improve the safety of patients'medication.
sodium valproateplateletsfibrinogenadverse reactionspharmaceutical care
NETL
NSTL
万方数据
